A CD30(-) transformed mycosis fungoides case responding very well to systemic bexarotene and methotrexate
International Journal of Lower Extremity Wounds, cilt.13, sa.2, ss.127-129, 2014 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 13 Sayı: 2
- Basım Tarihi: 2014
- Doi Numarası: 10.1177/1534734614534978
- Dergi Adı: International Journal of Lower Extremity Wounds
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.127-129
- Anahtar Kelimeler: mycosis fungoides (MF), CD30(-) transformed MF, methotraxe and bexarotene therapy, ulcer
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
The course of mycosis fungoides (MF) is indolent except when transformation to a large T-cell lymphoma occurs. The diagnosis of transformed MF relies on the presence of more than 25% of large cells on biopsy of an MF lesion. Treatment of transformed MF is a major challenge as these patients have poor outcome. Here, we report a 61-year-old man presenting with tumoral ulcer on the plantar area of the foot who was diagnosed cutaneous CD30(-) large cell transformed MF and treated with systemic methotraxate and bexarotene therapy. © 2014 The Author(s).